General Updates

Shilpa Medicare Limited Corporate & Admin Office: “Shilpa House”, # 12-6-214/A-1, Hyderabad Road, Raichur – 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 Date: 17 August 2026 Corporate Relationship Department, National Stock Exchange of India Limited BSE Limited Exchange Plaza, 5th Floor, Phiroze Jeejeebhoy Towers, Plot No.C/1, G Block Dalal Street, Fort, Bandra Kurla Complex, Bandra (E) Mumbai-400 001 Mumbai-400 051 Stock Code: NSE: SHILPAMED/BSE-530549 Dear Madam/Sir, Sub: Communication sent to the Shareholders of the Company for the Intimation of Deduction of Tax at Source (TDS) on Final Dividend. Pursuant to Regulation 30 read with schedule III (Part A) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith an e-mail communication sent to all the shareholders of the Company regarding Communication on deduction of tax on Final Dividend on 17th August, 2026. This communication is also being made available on the website www.vbshilpa.com. This is for your information and records. Thanking you For Shilpa Medicare Limited Ritu Tiwary Company Secretary & Compliance Officer Shilpa Medicare Limited Corporate & Admin Office: “Shilpa House”, # 12-6-214/A-1, Hyderabad Road, Raichur – 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 SHILPA MEDICARE LIMITED Regd Off: #12-6-214/A-1, Shilpa House, Hyderabad Road, Raichur - 584 135, Karnataka Phone: +91 8532 - 238704, E-Mail: cs@vbshilpa.com. Website: http://www.vbshilpa.com CIN: L85110KA1987PLC008739 August 17, 2026 Ref: Folio / DP Id & Client Id No: Name of the Shareholder: Dear Shareholder(s), We would like to inform you that the Board of Directors of Shilpa Medicare Limited('the Company') at its meeting held on Friday, 22nd May, 2026, has recommended a Dividend of Re. 0.60/- per Equity Share of Re. 1/- each for the financial year ended March 31, 2026. The Board has fixed Friday, 4 September, 2026, as the record date for determining entitlement of members to receive the Final dividend. The dividend, if approved by the Shareholders, will be paid within the prescribed period of 30 days from the date of the forthcoming Annual General Meeting scheduled to be held on Friday, 11 September, 2026. As per the Indian Income Tax Act, 2025 (Act), dividend paid and distributed by a Company is taxable in the hands of the Shareholders. Therefore, the Company is required to deduct tax at source (TDS), at the rates applicable on the amount distributed To the shareholders. All Shareholders are requested to ensure that the details such as Permanent Account Number (PAN), residential status, category of Shareholder (e.g., Domestic Company, Foreign Company, Individual, Firm, LLP, HUF, Foreign Portfolio Investors / Foreign Institutional Investors, Government, Trust, Alternate Investment Fund - Category I, II or III, etc.), email id and address, bank mandate are updated, in their respective demat account(s) maintained with the Depository Participants. Please note that these details as available on the Record Date will be relied upon by the Company for the purpose of Complying with the applicable withholding tax provisions. The TDS/ Withholding tax provisions for both categories of shareholders viz. Resident and Non-Resident are detailed below: Shilpa Medicare Limited Corporate & Admin Office: “Shilpa House”, # 12-6-214/A-1, Hyderabad Road, Raichur – 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 I. Resident shareholders: In respect of Resident Shareholders, Tax will be deducted at source ("TDS") under Section 393(1) of the Act at the rate of 10% on the amount of dividend payable unless exempt under any other provisions of the Act subject to the following conditions: 1. Valid PAN mandatorily required. 2. Shareholders holding shares under multiple accounts under different status/ category (e.g., Resident and Non-Resident) and single PAN, higher of the tax as applicable to the status in which shares held under a PAN will be considered on their entire holding in different accounts. 3. For shareholders who have not linked PAN and Aadhaar, the PAN will be considered as invalid and higher rate of taxes shall apply. Please note that for the purpose of point 3 above, the company will undertake the verification from the Government enabled online facility and deduct TDS accordingly. Apart from the above, specific provisions applicable to Resident-Individuals and Resident Non- Individuals are given below for ready reference. IA. Resident Shareholders (Individual(s)): 1. The TDS would not apply if the aggregate of total dividend paid to individual shareholders by the Company under folio(s) during FY 2026-27 does not exceed Rs. 10,000/-. 2. Tax will not be deducted at source in cases where a shareholder provides duly signed Form 121 (applicable to a resident individual provided that the eligibility conditions as mentioned in the Income Tax Act are met. Click here to download Form 121- Annexure I 3. Valid PAN mandatorily required. However, if the PAN is not updated or is invalid or is deleted or becomes inoperative on account of non-linking with Aadhaar then the higher rate as per the section 397 (2)(b) of the Act (i.e., 20%) would apply. IB. Resident Shareholders (Other than Individual(s)): The TDS for Resident shareholders (other than individuals) along with required documents are provided in Table below: Category of Tax Deduction Exemption Applicability/ Documents required Shareholder Rate Shilpa Medicare Limited Corporate & Admin Office: “Shilpa House”, # 12-6-214/A-1, Hyderabad Road, Raichur – 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 Insurance NIL Declaration by shareholder qualifying as Insurer as per Companies Section 2(7A) of the Insurance Act, 1938 Annexure-II Mutual Funds NIL Declaration by Mutual Fund shareholder as specified at Schedule VII (Table: Sl. No 20 or 21) of the Income Tax Act, 2025 - Annexure -III Alternative NIL Declaration by Category I/II Alternate Investment Fund (AIF) Investment fund registered with SEBI specified at Schedule V (Table: Sl. No 1) (AIF) established/ Annexure -IV incorporated in India Other - Resident As applicable In case your income is subject to a lower rate of TDS, or is Company / Firm / exempt under the Income Tax Act, 2025, you are requested HUF / AOP / Trust to submit the following forms or documents attached as Annexures if eligible as per the relevant provisions of the Income Tax Act, 2025, duly signed by the authorized signatory on the Shareholder Portal on or before September 02 ,2026: a) Lower withholding tax certificate for the Tax Year 2026-27 if any obtained from the Income Tax authorities. b) In case you have tax exemption status under any provisions of the Income Tax Act, submit the documentary evidence along with declaration for the same. - Annexure -V c) Any other documents as prescribed under the Income Tax Act if applicable. - Annexure -VI II. Non-resident Shareholders In respect of Non-Resident Shareholders, Tax will be deducted at source under Section 393 the Act at applicable rates (plus applicable surcharge and cess) on the amount of dividend payable unless exempt under the provisions of the Act as given below: Category of Tax Deduction Exemption Applicability/ Documents required Shareholder Rate Any non-resident 20% (plus As per Section 159 of the Act, a non-resident shareholder has shareholder applicable an option to be governed by the provisions of the Double (including Foreign surcharge and Taxation Avoidance Agreement ('DTAA') between India and Institutional cess) or Tax Treaty the country of tax residence of the shareholder, if such D [Showing first 8,000 characters — download PDF for full document]